White paper: Xbiom - Accelerating innovation in BioPharma
This paper discusses best practices to optimize cross-functional processes in Biopharma R&D not just to create better efficiencies but to do it by accelerating innovation, and anticipating the disruptive changes in how clinical trials will be conducted in the coming years.
The paper will contemplate the nature of disruptive changes to come in the way clinical trials are planned and conducted. Ideas such as those fostered by Verily and Google, and ideas on “Deep Medicine” (by Dr. Eric Topol) and how AI will inject itself in various aspect of trial designs will change the way organization will need to think of data and how it should be reposed, and re-purposed. We will show how the Smart Transformation capabilities of Xbiom serve these needs.